🇺🇸 FDA
Patent

US 6331564

Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease

expired A61KA61K31/03A61K31/05

Quick answer

US patent 6331564 (Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease) held by Ion Pharmaceuticals, Inc. expires Mon Dec 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Ion Pharmaceuticals, Inc.
Grant date
Tue Dec 18 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/03, A61K31/05, A61K31/075, A61K31/085